Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials.

Gustavo de Oliveira AlmeidaThiago Faraco NienkötterCaroline Cristine Almeida BalieiroEric PasqualottoJúlia Braga CintraHenrique Champs Porfírio CarvalhoAna Laura Soares SilvaJúlia Camargo KabaritiBárbara Silvestre MinucciEdmundo Damiani BertoliCamila Mota Guida

Published in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2024)

PROSPERO identifier number CRD42023475226.

Keyphrases

end stage renal disease
weight loss
newly diagnosed
chronic kidney disease
metabolic syndrome
systematic review
type diabetes
weight gain
insulin resistance
prognostic factors
peritoneal dialysis
physical activity
high fat diet induced